Non-invasive Blood Glucose Monitoring Devices Market By Technology, Modality And End User- Global Industry Analysis And Forecast To 2023
Published On : June 2022 Pages : 180 Category: Medical Devices Report Code : HC06994
Non-Invasive Blood Glucose Monitoring Devices Market by Technology (Bio-impedance spectroscopy, Electromagnetic sensing, Fluorescence, Mid-infrared/Near infrared spectroscopy, Optical coherence tomography, Optical polarimetry, Raman spectroscopy, Reverse iontophoresis, Ultrasound technology), Modality (Wearable, Non-wearable / table top), End User (Hospitals & Clinics, Diagnostic Centers, Homecare Setting) Forecast to 2017 to 2023
Industry Outlook and Trend Analysis
The Non-Invasive Blood Glucose Monitoring Devices Market is expected to witness considerable growth during the forecast period. Non-invasive blood glucose monitoring devices measures blood glucose levels in patients experiencing diabetes, without puncturing the skin, or causing agony or injury. The successive change in blood glucose levels in diabetic patients must be followed by the glucose monitoring devices. Glucose monitoring devices can be obtrusive or non-intrusive yet the Non-invasive blood glucose monitoring devices market is expanding because of the need of a financial, reduced and easy and accommodation for the patients to utilize. Non-invasive blood glucose monitoring devices glucose observing holds incredible guarantee for enhancing diabetes administration by giving better and torment free blood glucose estimation prompting development of Non-invasive blood glucose screen showcase in the gauge time frame.
Drivers & Restrains
The worldwide non-invasive blood glucose monitoring devices market is required to be helped by the expanding diabetes pervasiveness. As per World Health Organisation (WHO), in 2017, diabetes mellitus is an overall scourge ailment influencing 422 million individuals and seventh driving reason for death in US. The glucose grouping of diabetic patients varies fundamentally for the duration of the day which can prompt genuine results like kidney disappointment, strokes, heart assaults, hypertension, visual deficiency and unconsciousness. These request the mechanically propelled gadgets for visit checking of blood glucose levels. Also, the intrusive methods of blood glucose screen are difficult and costly when contrasted with non-invasive blood glucose monitoring devices; this makes the device, as the gadget of decision among the patients. Besides, the high level of prediabetes patients, a condition were blood glucose levels are high however not adequate to recognize the diabetes, will likewise move the non-invasive blood glucose monitoring devices market in the figure time frame. As indicated by NIDDK, in 2017, 33.9% of US grown-ups are assessed to be prediabetes, at expanded danger of developing type 2 diabetes.
Regional Outlook and Trend Analysis
North America is expected to witness considerable growth over the forecast period. North America is relied upon to be overwhelming district as for non-invasive blood glucose monitoring devices market because of high predominance of ailment in geriatric population which is 25.2 % in US population according to American Diabetes Association of year 2017.
Competitive Insights
The leading players in the market are Hoffmann-La Roche Ltd., Integrity Applications, Inc., Abbott Laboratories and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Non-Invasive Blood Glucose Monitoring Devices Market is region-wise segmented as follows-
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, Estimates and Forecast, 2014-2023($Billion)
o Bio-impedance spectroscopy
o Electromagnetic sensing
o Fluorescence
o Mid-infrared / Near infrared spectroscopy
o Optical coherence tomography
o Optical polarimetry
o Raman spectroscopy
o Reverse iontophoresis
o Ultrasound technology
· Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, Estimates and Forecast, 2014-2023($Billion)
o Wearable
o Non-wearable / Table top
· Non-Invasive Blood Glucose Monitoring Devices Market, By End User, Estimates and Forecast, 2014-2023($Billion)
o Hospitals & Clinics
o Diagnostic centers
o Homecare setting
· Non-Invasive Blood Glucose Monitoring Devices Market, By Region, Estimates and Forecast, 2014-2023($Billion)
o North America
§ North America Non-Invasive Blood Glucose Monitoring Devices Market, By Country
o U.S. Non-Invasive Blood Glucose Monitoring Devices Market
o Canada Non-Invasive Blood Glucose Monitoring Devices Market
o Mexico Non-Invasive Blood Glucose Monitoring Devices Market
o Europe
§ Europe Non-Invasive Blood Glucose Monitoring Devices Market, By Country
o Germany Non-Invasive Blood Glucose Monitoring Devices Market
o UK Non-Invasive Blood Glucose Monitoring Devices Market
o France Non-Invasive Blood Glucose Monitoring Devices Market
o Russia Non-Invasive Blood Glucose Monitoring Devices Market
o Italy Non-Invasive Blood Glucose Monitoring Devices Market
o Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Market
o Asia-Pacific
§ Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Market, By Country
o China Non-Invasive Blood Glucose Monitoring Devices Market
o Japan Non-Invasive Blood Glucose Monitoring Devices Market
o South Korea Non-Invasive Blood Glucose Monitoring Devices Market
o India Non-Invasive Blood Glucose Monitoring Devices Market
o Southeast Asia Non-Invasive Blood Glucose Monitoring Devices Market
o Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Market
o South America
§ South America Non-Invasive Blood Glucose Monitoring Devices Market
o Brazil Non-Invasive Blood Glucose Monitoring Devices Market
o Argentina Non-Invasive Blood Glucose Monitoring Devices Market
o Columbia Non-Invasive Blood Glucose Monitoring Devices Market
o South Africa Non-Invasive Blood Glucose Monitoring Devices Market
o Rest of South America Non-Invasive Blood Glucose Monitoring Devices Market
o Middle East and Africa
§ Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Market
o Saudi Arabia Non-Invasive Blood Glucose Monitoring Devices Market
o UAE Non-Invasive Blood Glucose Monitoring Devices Market
o Egypt Non-Invasive Blood Glucose Monitoring Devices Market
o Nigeria Non-Invasive Blood Glucose Monitoring Devices Market
o South Africa Non-Invasive Blood Glucose Monitoring Devices Market
o Rest of MEA Non-Invasive Blood Glucose Monitoring Devices Market
Table of Contents
Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
Chapter 4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
Chapter 5. Non-Invasive Blood Glucose Monitoring Devices Market, By Technology
5.1. Introduction
5.2. Global Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Market Share by Technology (2017-2027)
5.2.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales and Sales Share by Technology (2017-2027)
5.2.2. Global Non-Invasive Blood Glucose Monitoring Devices Revenue and Revenue Share by Technology (2017-2027)
5.3. Bio-Impedance Spectroscopy
5.3.1. Global Bio-Impedance Spectroscopy Sales and Growth Rate (2017-2027)
5.4. Electromagnetic Sensing
5.4.1. Global Electromagnetic Sensing Sales and Growth Rate (2017-2027)
5.5. Fluorescence
5.5.1. Global Fluorescence Sales and Growth Rate (2017-2027)
5.6. Mid-infrared / Near infrared Spectroscopy
5.6.1. Global Mid-infrared / Near infrared Spectroscopy Sales and Growth Rate (2017-2027)
5.7. Optical Coherence Tomography
5.7.1. Global Optical Coherence Tomography Sales and Growth Rate (2017-2027)
5.8. Optical Polarimetry
5.8.1. Global Optical Polarimetry Sales and Growth Rate (2017-2027)
5.9. Raman spectroscopy
5.9.1. Global Raman Spectroscopy Sales and Growth Rate (2017-2027)
5.10. Reverse iontophoresis
5.10.1. Global Reverse Iontophoresis Sales and Growth Rate (2017-2027)
5.11. Ultrasound technology
5.11.1. Global Ultrasound Technology Sales and Growth Rate (2017-2027)
Chapter 6. Non-Invasive Blood Glucose Monitoring Devices Market, By Modality
6.1. Introduction
6.2. Global Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Market Share by Modality (2017-2027)
6.2.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales and Sales Share by Modality (2017-2027)
6.2.2. Global Non-Invasive Blood Glucose Monitoring Devices Revenue and Revenue Share by Modality (2017-2027)
6.3. Wearable
6.3.1. Global Wearable Sales and Growth Rate (2017-2027)
6.4. Non-wearable / Table top
6.4.1. Global Non-wearable / Table top Sales and Growth Rate (2017-2027)
Chapter 7. Non-Invasive Blood Glucose Monitoring Devices Market, By End User
7.1. Introduction
7.2. Global Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Market Share by End User (2017-2027)
7.2.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales and Sales Share by End User (2017-2027)
7.2.2. Global Non-Invasive Blood Glucose Monitoring Devices Revenue and Revenue Share by End User (2017-2027)
7.3. Hospitals & Clinics
7.3.1. Global Hospitals & Clinics Sales and Growth Rate (2017-2027)
7.4. Diagnostic Centers
7.4.1. Global Diagnostic Centers Sales and Growth Rate (2017-2027)
7.5. Homecare Setting
7.5.1. Global Homecare Setting Sales and Growth Rate (2017-2027)
Chapter 8. Non-Invasive Blood Glucose Monitoring Devices Market, By Region
8.1. Introduction
8.2. Global Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Market Share by Regions
8.2.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales by Regions (2017-2027)
8.2.2. Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Regions (2017-2027)
8.3. North America Non-Invasive Blood Glucose Monitoring Devices by Countries
8.3.1. North America Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.3.2. North America Non-Invasive Blood Glucose Monitoring Devices Revenue and Growth Rate (2017-2027)
8.3.3. North America Non-Invasive Blood Glucose Monitoring Devices Sales by Countries (2017-2027)
8.3.4. North America Non-Invasive Blood Glucose Monitoring Devices Revenue (Million USD) by Countries (2017-2027)
8.3.5. U.S.
8.3.5.1. United States Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.3.5.2. United States Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Canada
8.3.6.1. Canada Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.3.6.2. Canada Non-Invasive Blood Glucose Monitoring Devices Sales (Millions USD) and Growth Rate (2017-2027)
8.3.7. Mexico
8.3.7.1. Mexico Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.3.7.2. Mexico Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Non-Invasive Blood Glucose Monitoring Devices by Countries
8.4.1. Europe Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.4.2. Europe Non-Invasive Blood Glucose Monitoring Devices Revenue and Growth Rate (2017-2027)
8.4.3. Europe Non-Invasive Blood Glucose Monitoring Devices Sales by Countries (2017-2027)
8.4.4. Europe Non-Invasive Blood Glucose Monitoring Devices Revenue (Million USD) by Countries (2017-2027)
8.4.5. Germany
8.4.5.1. Germany Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.4.5.2. Germany Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. UK
8.4.6.1. UK Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.4.6.2. UK Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. France
8.4.7.1. France Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.4.7.2. France Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Russia
8.4.8.1. Russia Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.4.8.2. Russia Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Italy
8.4.9.1. Italy Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.4.9.2. Italy Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.10. Rest of Europe
8.4.10.1. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.4.10.2. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Revenue and Growth Rate (2017-2027)
8.5.3. Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales by Countries (2017-2027)
8.5.4. Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Revenue (Million USD) by Countries (2017-2027)
8.5.5. China
8.5.5.1. China Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.5.5.2. China Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. Japan
8.5.6.1. Japan Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.5.6.2. Japan Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6.3.
8.5.7. Korea
8.5.7.1. Korea Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.5.7.2. Korea Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. India
8.5.8.1. India Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.5.8.2. India Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Southeast Asia
8.5.9.1. Southeast Asia Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.5.9.2. Southeast Asia Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.10. Rest of Asia-Pacific
8.5.10.1. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.5.10.2. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.6.2. South America Non-Invasive Blood Glucose Monitoring Devices Revenue and Growth Rate (2017-2027)
8.6.3. South America Non-Invasive Blood Glucose Monitoring Devices Sales by Countries (2017-2027)
8.6.4. South America Non-Invasive Blood Glucose Monitoring Devices Revenue (Million USD) by Countries (2017-2027)
8.6.5. Brazil
8.6.5.1. Brazil Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.6.5.2. Brazil Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Argentina
8.6.6.1. Argentina Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.6.6.2. Argentina Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Columbia
8.6.7.1. Columbia Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.6.7.2. Columbia Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.8. Rest of South America
8.6.8.1. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.6.8.2. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Revenue and Growth Rate (2017-2027)
8.7.3. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales by Countries (2017-2027)
8.7.4. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Revenue (Million USD) by Countries (2017-2027)
8.7.5. Saudi Arabia
8.7.5.1. Saudi Arabia Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.7.5.2. Saudi Arabia Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. United Arab Emirates
8.7.6.1. United Arab Emirates Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.7.6.2. United Arab Emirates Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Egypt
8.7.7.1. Egypt Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.7.7.2. Egypt Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Nigeria
8.7.8.1. Nigeria Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.7.8.2. Nigeria Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. South Africa
8.7.9.1. South Africa Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.7.9.2. South Africa Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.10. Rest of Middle East and Africa
8.7.10.1. Rest of Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales and Growth Rate (2017-2027)
8.7.10.2. Rest of Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Revenue (Millions USD) and Growth Rate (2017-2027)
Chapter 9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Sales, Revenue and Market Share
9.2. F. Hoffmann-La Roche Ltd.
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Sales, Revenue and Market Share
9.3. Integrity Applications, Inc.
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Sales, Revenue and Market Share
9.4. Bayer Healthcare
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Sales, Revenue and Market Share
9.5. Pendragon Medical
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Sales, Revenue and Market Share
9.6. Animas Technologies
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Sales, Revenue and Market Share
9.7. Omron
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Sales, Revenue and Market Share
9.8. OrSense
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Sales, Revenue and Market Share
Chapter 10. Global Non-Invasive Blood Glucose Monitoring Devices Market Competition, by Manufacturer
10.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales and Market Share by Manufacturer (2017-2017)
10.2. Global Non-Invasive Blood Glucose Monitoring Devices Revenue and Market Share by Manufacturer (2017-2017)
10.3. Global Non-Invasive Blood Glucose Monitoring Devices Price by Manufacturer (2017-2017)
10.4. Top 5 Non-Invasive Blood Glucose Monitoring Devices Manufacturer Market Share
10.5. Market Competition Trend
Chapter 11. Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Non-Invasive Blood Glucose Monitoring Devices Market Forecast by Regions (2027-2023)
11.2.1. North America Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.1.1. United States Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.1.2. Canada Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.1.3. Mexico Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.2. Europe Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.2.1. Germany Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.2.2. United Kingdom Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.2.3. France Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.2.4. Russia Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.2.5. Italy Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.3. Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.3.1. China Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.3.2. Japan Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.3.3. Korea Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.3.4. India Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.4. South America Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.4.1. Brazil Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.4.2. Argentina Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.4.3. Columbia Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.4.4. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.5. Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.5.2. UAE Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.5.3. Egypt Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.5.4. Nigeria Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.5.5. South Africa Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Non-Invasive Blood Glucose Monitoring Devices Market Forecast (2027-2023)
11.3. Non-Invasive Blood Glucose Monitoring Devices Market Forecast by Technology (2027-2023)
11.3.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales Forecast by Technology (2027-2023)
11.3.2. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share Forecast by Technology (2027-2023)
11.4. Non-Invasive Blood Glucose Monitoring Devices Market Forecast by Modality (2027-2023)
11.4.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales Forecast by Modality (2027-2023)
11.4.2. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share Forecast by Modality (2027-2023)
11.5. Non-Invasive Blood Glucose Monitoring Devices Market Forecast by End User (2027-2023)
11.5.1. Global Non-Invasive Blood Glucose Monitoring Devices Sales Forecast by End User (2027-2023)
11.5.2. Global Non-Invasive Blood Glucose Monitoring Devices Sales Market Share Forecast by End User (2027-2023)
List of Tables
(*You can glance through the list of Tables and Figures when you view the sample copy of Non-Invasive Blood Glucose Monitoring Devices Market.)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|